Evaluation of Minimum Clinically Meaningful Changes in Scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19

REFERENCES

• Submacular Surgery Trials Research Group. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery. SST report no. 4. Am J Ophthalmol 2004; 138: 91–108
   Google Scholar
• Submacular Surgery Trials Research Group. Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery. SST report no. 5. Arch Ophthalmol 2005; 123: 78–88
   Google Scholar
• Mangione C M, Berry S, Spritzer K, Janz N K, Klein R, Owsley C, Lee P P. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: Results from focus groups with visually impaired persons. Arch Ophthalmol. 1998; 116: 227–233
   PubMed Web of Science ®Google Scholar
• Mangione C M, Lee P P, Pitts J, Gutierrez P, Berry S, Hays R D, for the NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 1998; 116: 1496–1504
   PubMed Web of Science ®Google Scholar
• Mangione C M, Lee P P, Gutierrez P R, Spritzer K, Berry S, Hays R D, for the NEI-VFQ Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119: 1050–1058
   PubMed Web of Science ®Google Scholar
• Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularization—SST report no. 1. Arch Ophthalmol 2003; 121: 531–539
   Google Scholar
• Submacular Surgery Trials Research Group. Surgical removal vs. observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial. SST report no. 10. Arch Ophthalmol 2004; 122: 1616–1628
   Google Scholar
• Submacular Surgery Trials (SST) Research Group. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findings. SST report no. 12. Ophthalmology 2004; 111: 1981–1992
   Google Scholar
• Cella D, Eton D T, Lai J-S, Perman A H, Merkel D E. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002; 24: 547–561
   PubMed Web of Science ®Google Scholar
• Crosby R D, Kolotkin R L, Williams G R. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003; 56: 395–407
   PubMed Web of Science ®Google Scholar
• Gliklich R E, Hilinski J M. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res 1995; 4: 27–32
   Google Scholar
• Submacular Surgery Trials Research Group. Submacular Surgery Trials (SST) Manual of Procedures. U.S. Department of Commerce, National Technical Information Service, Springfield, VA June, 1998, NTIS accession no. PB98-166648
   Google Scholar
• Submacular Surgery Trials (SST) Research Group. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findings. SST report no. 11. Ophthalmology 2004; 111: 1967–1980
   PubMed Web of Science ®Google Scholar
• Submacular Surgery Trials Research Group. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. I. Ophthalmic findings from a randomized clinical trial: SST Group H Trial. SST report no. 9. Arch Ophthalmol 2004; 122: 1597–1611
   Google Scholar
• Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findings. SST report no. 13. Ophthalmology 2004; 111: 1993–2006
   Google Scholar
• Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings. SST report no. 14. Ophthalmology 2004; 111: 2007–2014
   Google Scholar
• Ware J E, Kosinski M, Keller S D. SF-36 Physical and Mental Health Summary Scales: A User's Manual. The Health Institute, New England Medical Center, Boston 1994
   Google Scholar
• Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361–370
   PubMed Web of Science ®Google Scholar
• Submacular Surgery Trials Research Group. Patients' perceptions of the value of current vision. Assessment of preference values among patients with subfoveal choroidal neovascularization—The Submacular Surgery Trials Vision Preference Value Scale: SST report no. 6. Arch Ophthalmol 2004; 122: 1856–1867
   Google Scholar
• Miskala P H, Bressler N M, Meinert C L. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol. 2004; 122: 758–766
   PubMed Web of Science ®Google Scholar
• Miskala P H, Bressler N M, Meinert C L. Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials?. Am J Ophthalmol. 2004; 137: 961–963
   PubMed Web of Science ®Google Scholar
• Ferris F L, Kassoff A, Bresnick G H, Bailey I. New visual acuity charts for clinical research. Am J. Ophthalmol. 1982; 94: 91–98
   Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences, Second Edition. Lawrence Erlbaum Associates, Hillsdale, NJ 1988; 19–27
   Google Scholar
• Age-Related Eye Disease Study Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity. AREDS report no. 14. Arch Ophthalmol 2005; 123: 1207–1214
   Google Scholar